These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1349799

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
    Serio G.
    Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
    [Abstract] [Full Text] [Related]

  • 6. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
    Offner FA, Schäfer G, Hittmair A, Ofner D, Grünewald K, Weyrer K, Mattern D, Eberle J, Mikuz G, Feichtinger H.
    Verh Dtsch Ges Pathol; 1993 Apr; 77():241-6. PubMed ID: 7511289
    [Abstract] [Full Text] [Related]

  • 7. [Growth fractions of bladder cancer determined by proliferating cell nuclear antigen immunostaining].
    Kuroda H, Yasunaga Y, Takatera H, Fujioka H, Ohnishi A, Tsujimoto M.
    Hinyokika Kiyo; 1994 May; 40(5):379-82. PubMed ID: 7912881
    [Abstract] [Full Text] [Related]

  • 8. [Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder].
    Kuczyk MA, Serth J, Bokemeyer C, Hervatin C, Oelke M, Oelert F, Höfner K, Jonas U.
    Urologe A; 1995 Mar; 34(2):146-52. PubMed ID: 7754587
    [Abstract] [Full Text] [Related]

  • 9. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.
    Waldman FM, Carroll PR, Cohen MB, Kerschmann R, Chew K, Mayall BH.
    Mod Pathol; 1993 Jan; 6(1):20-4. PubMed ID: 8093979
    [Abstract] [Full Text] [Related]

  • 10. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K, Kosma VM.
    Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
    [Abstract] [Full Text] [Related]

  • 11. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI.
    Br J Cancer; 2001 May 04; 84(9):1242-51. PubMed ID: 11336477
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract.
    Cheng HL, Chow NH, Tzai TS, Tong YC, Lin JS, Chan SH, Yang WH, Chang CC, Lin YM.
    Anticancer Res; 1997 May 04; 17(4A):2789-93. PubMed ID: 9252716
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67).
    Mulder AH, Van Hootegem JC, Sylvester R, ten Kate FJ, Kurth KH, Ooms EC, Van der Kwast TH.
    J Pathol; 1992 Jan 04; 166(1):37-43. PubMed ID: 1538273
    [Abstract] [Full Text] [Related]

  • 14. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 04; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 15. [Monoclonal antibodies (MIB 1, PC 10, 486p and p53) as prognostic factors for recurrent urothelial carcinoma of the urinary bladder].
    Hake R, Vorreuther R, Borchmann P, Lukowsky S, Thiele J, Fischer R.
    Verh Dtsch Ges Pathol; 1993 May 04; 77():236-40. PubMed ID: 7511288
    [Abstract] [Full Text] [Related]

  • 16. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC, Terrell RB, Cohen MB.
    Mod Pathol; 1994 Sep 04; 7(7):794-800. PubMed ID: 7824516
    [Abstract] [Full Text] [Related]

  • 17. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F, Hiroi M, Yamane T, Hara H.
    Zentralbl Pathol; 1993 Aug 04; 139(3):185-93. PubMed ID: 8105885
    [Abstract] [Full Text] [Related]

  • 18. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
    Osman I, Scher H, Zhang ZF, Soos TJ, Hamza R, Eissa S, Khaled H, Koff A, Cordon-Cardo C.
    Clin Cancer Res; 1997 Dec 04; 3(12 Pt 1):2247-51. PubMed ID: 9815621
    [Abstract] [Full Text] [Related]

  • 19. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P.
    Hum Pathol; 2000 Jun 04; 31(6):751-60. PubMed ID: 10872671
    [Abstract] [Full Text] [Related]

  • 20. [Expression of proliferating cell nuclear antigen in superficial bladder cancer--application to paraffin-embedded tissue sections].
    Wada T, Shimabukuro T, Kurisu H, Shameem IA, Yoshihiro S, Matsuyama H, Naito K, Hashimoto O, Tanaka K.
    Hinyokika Kiyo; 1993 Apr 04; 39(4):313-9. PubMed ID: 8099249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.